<DOC>
	<DOCNO>NCT02839408</DOCNO>
	<brief_summary>The aim randomize placebo- control clinical trial evaluate effect Lactobacillus rhamnosus SP1- contain probiotic tablet azithromycin tablet adjunct scale root planning ( SRP ) . Material method : Fifty-four chronic periodontitis patient recruit monitored clinically , immunologically microbiologically baseline , 3 , 6 , 9 12 month therapy . All patient receive scale root planning randomly assign probiotic experimental ( SRP + probiotic , n=18 ) , antibiotic experimental ( SRP + Azithromycin , n=18 ) control ( SRP + placebo , n=18 ) group . Probiotic use per day 3 month . Antibiotic use per day 5 day .</brief_summary>
	<brief_title>Efficacy Oral Probiotic Antibiotic Administration Patients With Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>14 natural teeth , exclude third molar 10 posterior teeth 35 year old 5 teeth periodontal site probe depth ≥5mm , clinical attachment loss ≥3mm Bleeding probe ≥20 % site Extensive bone loss determine radiographically Periodontal treatment time examination Systemic illness Pregnancy Anticoagulant , antibiotic non steroid anti inflammatory therapy 6month period study</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>periodontitis</keyword>
	<keyword>azithromycin</keyword>
	<keyword>probiotic</keyword>
</DOC>